Analysis of Factors Predicting Treatment Response of 254 Patients Who Received CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Category Primary study
JournalBlood
Year 2019
This article has no abstract
Epistemonikos ID: 46dc31fce3bb772f9ce8ad19e4de274e5a5ca7b9
First added on: Feb 13, 2025